These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33839076)

  • 21. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
    Wolsk E; Kaye D; Komtebedde J; Shah SJ; Borlaug BA; Burkhoff D; Kitzman DW; Lam CSP; van Veldhuisen DJ; Ponikowski P; Petrie MC; Hassager C; Møller JE; Gustafsson F
    JACC Heart Fail; 2019 Apr; 7(4):321-332. PubMed ID: 30852235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction.
    Dorfs S; Zeh W; Hochholzer W; Jander N; Kienzle RP; Pieske B; Neumann FJ
    Eur Heart J; 2014 Nov; 35(44):3103-12. PubMed ID: 25161181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea.
    Reddy YNV; Kaye DM; Handoko ML; van de Bovenkamp AA; Tedford RJ; Keck C; Andersen MJ; Sharma K; Trivedi RK; Carter RE; Obokata M; Verbrugge FH; Redfield MM; Borlaug BA
    JAMA Cardiol; 2022 Sep; 7(9):891-899. PubMed ID: 35830183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial.
    Chieng D; Sugumar H; Segan L; Tan C; Vizi D; Nanayakkara S; Al-Kaisey A; Hawson J; Prabhu S; Voskoboinik A; Finch S; Morton JB; Lee G; Mariani J; La Gerche A; Taylor AJ; Howden E; Kistler PM; Kalman JM; Kaye DM; Ling LH
    JACC Heart Fail; 2023 Jun; 11(6):646-658. PubMed ID: 36868916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
    Udelson JE; Lewis GD; Shah SJ; Zile MR; Redfield MM; Burnett J; Parker J; Seferovic JP; Wilson P; Mittleman RS; Profy AT; Konstam MA
    JAMA; 2020 Oct; 324(15):1522-1531. PubMed ID: 33079154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamic and efficacies of domestic levosimendan versus dobutamine in patients with acute decompensated heart failure].
    Zhang YH; Qing EM; Zhang J; Huang Y; Lü R; Zhou Q; Wei BQ; An T; Qing P; Zou CH
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):555-8. PubMed ID: 22490161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.
    Kaye D; Shah SJ; Borlaug BA; Gustafsson F; Komtebedde J; Kubo S; Magnin C; Maurer MS; Feldman T; Burkhoff D
    J Card Fail; 2014 Mar; 20(3):212-21. PubMed ID: 24487087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Circulation; 1998 Mar; 97(9):886-91. PubMed ID: 9521337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
    Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA
    J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure.
    Andersen MJ; Olson TP; Melenovsky V; Kane GC; Borlaug BA
    Circ Heart Fail; 2015 Jan; 8(1):41-8. PubMed ID: 25342738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    Bergh CH; Andersson B; Dahlström U; Forfang K; Kivikko M; Sarapohja T; Ullman B; Wikström G
    Eur J Heart Fail; 2010 Apr; 12(4):404-10. PubMed ID: 20335355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis.
    De Vecchis R; Cesaro A; Ariano C; Giasi A; Cioppa C
    J Clin Med Res; 2017 Jun; 9(6):488-498. PubMed ID: 28496549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension.
    Ryan JJ; Rich JD; Thiruvoipati T; Swamy R; Kim GH; Rich S
    Am Heart J; 2012 Apr; 163(4):589-94. PubMed ID: 22520524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
    Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective STudy using invAsive haemodynamic measurements foLLowing catheter ablation for AF and early HFpEF: STALL AF-HFpEF.
    Sugumar H; Nanayakkara S; Vizi D; Wright L; Chieng D; Leet A; Mariani JA; Voskoboinik A; Prabhu S; Taylor AJ; Kalman JM; Kistler PM; Kaye DM; Ling LH
    Eur J Heart Fail; 2021 May; 23(5):785-796. PubMed ID: 33565197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study.
    Shah B; Sharma P; Brahmbhatt A; Shah R; Rathod B; Shastri N; Patel J; Malhotra A
    Indian J Pharmacol; 2014; 46(1):29-34. PubMed ID: 24550581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.
    Borlaug BA; Anstrom KJ; Lewis GD; Shah SJ; Levine JA; Koepp GA; Givertz MM; Felker GM; LeWinter MM; Mann DL; Margulies KB; Smith AL; Tang WHW; Whellan DJ; Chen HH; Davila-Roman VG; McNulty S; Desvigne-Nickens P; Hernandez AF; Braunwald E; Redfield MM;
    JAMA; 2018 Nov; 320(17):1764-1773. PubMed ID: 30398602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction.
    Olson TP; Johnson BD; Borlaug BA
    JACC Heart Fail; 2016 Jun; 4(6):490-8. PubMed ID: 27256752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.